glp 1 south korea tightens oversight as GLP-1 obesity drug misuse rises Korean firm taps on GLP-1
Description
Participants with the highest body mass index (BMI) values (40 or above) were most likely to access semaglutide, which is not surprising given that this group has the highest risk for developing further metabolic diseasebut Podolsky says it reflects a trend that physicians may be restricting GLP-1 drugs to patients with the highest weight, and solely recommending lifestyle interventions to patients with BMI values of 35 or less
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis
The dual action produces enhanced insulin secretion, improved insulin sensitivity, greater appetite suppression, and more potent weight loss compared to GLP-1 activation alone
130 Earlier GLP-1RAs such as exenatide and liraglutide were linked to acute kidney injury 131 with case reports of acute interstitial nephritis (AIN)
The ProteomeXchange Consortium at 10 years: 2023 update
Prohormone convertases (PCs) are responsible for the tissue-specific processing
